<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.domesticanimalendo.com/?rss=yes"><title>Domestic Animal Endocrinology</title><description>Domestic Animal Endocrinology RSS feed: Current Issue.    
 
 
 
 
 Domestic Animal Endocrinology    publishes scientific papers dealing with the study of 
the endocrine physiology of domestic animal species. Those manuscripts utilizing other species as models for clinical or production problems 
associated with domestic animals are also welcome. 
 
Topics covered include: 
 
 
 
	classical and reproductive endocrinology 

 
 	clinical and applied endocrinology  
 	regulation of hormone secretion  
 	hormone action  
 	molecular 
biology  
 	cytokines  
 	growth factors 
 
   </description><link>http://www.domesticanimalendo.com/?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2012 Published by Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>Domestic Animal Endocrinology</prism:publicationName><prism:issn>0739-7240</prism:issn><prism:volume>42</prism:volume><prism:number>2</prism:number><prism:publicationDate>February 2012</prism:publicationDate><prism:copyright> © 2012 Published by Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.domesticanimalendo.com/article/PIIS0739724011001780/abstract?rss=yes"/><rdf:li rdf:resource="http://www.domesticanimalendo.com/article/PIIS0739724011001809/abstract?rss=yes"/><rdf:li rdf:resource="http://www.domesticanimalendo.com/article/PIIS0739724011001421/abstract?rss=yes"/><rdf:li rdf:resource="http://www.domesticanimalendo.com/article/PIIS0739724011001445/abstract?rss=yes"/><rdf:li rdf:resource="http://www.domesticanimalendo.com/article/PIIS0739724011001470/abstract?rss=yes"/><rdf:li rdf:resource="http://www.domesticanimalendo.com/article/PIIS0739724011001482/abstract?rss=yes"/><rdf:li rdf:resource="http://www.domesticanimalendo.com/article/PIIS0739724011001494/abstract?rss=yes"/><rdf:li rdf:resource="http://www.domesticanimalendo.com/article/PIIS0739724011001500/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.domesticanimalendo.com/article/PIIS0739724011001780/abstract?rss=yes"><title>Editorial Board</title><link>http://www.domesticanimalendo.com/article/PIIS0739724011001780/abstract?rss=yes</link><description></description><dc:title>Editorial Board</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/S0739-7240(11)00178-0</dc:identifier><dc:source>Domestic Animal Endocrinology 42, 2 (2012)</dc:source><dc:date>2012-02-01</dc:date><prism:publicationName>Domestic Animal Endocrinology</prism:publicationName><prism:publicationDate>2012-02-01</prism:publicationDate><prism:volume>42</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0739-7240(11)X0009-7</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>i</prism:startingPage><prism:endingPage>i</prism:endingPage></item><item rdf:about="http://www.domesticanimalendo.com/article/PIIS0739724011001809/abstract?rss=yes"><title>Contents</title><link>http://www.domesticanimalendo.com/article/PIIS0739724011001809/abstract?rss=yes</link><description></description><dc:title>Contents</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/S0739-7240(11)00180-9</dc:identifier><dc:source>Domestic Animal Endocrinology 42, 2 (2012)</dc:source><dc:date>2012-02-01</dc:date><prism:publicationName>Domestic Animal Endocrinology</prism:publicationName><prism:publicationDate>2012-02-01</prism:publicationDate><prism:volume>42</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0739-7240(11)X0009-7</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>iii</prism:startingPage><prism:endingPage>iii</prism:endingPage></item><item rdf:about="http://www.domesticanimalendo.com/article/PIIS0739724011001421/abstract?rss=yes"><title>Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its expected roles in the bovine endometrium during gestation</title><link>http://www.domesticanimalendo.com/article/PIIS0739724011001421/abstract?rss=yes</link><description>Abstract: 
Extracellular matrix metalloproteinase inducer (EMMPRIN) and its induced matrix metalloproteinases (MMPs) play a crucial role in tissue remodeling during the peri-implantation period. However, the role of EMMPRIN in the bovine placenta is still unclear. We have postulated that EMMPRIN might play a regulatory role in trophoblastic cell functions during gestation by itself or through the regulation of MMP expression. In this study, EMMPRIN mRNA was detected in the bovine placentome and interplacentome throughout gestation, and its expression was significantly higher in the cotyledon during late gestation. In situ hybridization showed that EMMPRIN mRNA was expressed in the caruncular epithelium and the cotyledonary epithelium, including binucleate cells. Western blot analysis detected a band representing a protein of approximately 65 kDa in the caruncular and cotyledonary tissues, and the intensity of its expression was increased in both of these tissues during late gestation. The expression levels of MMP-2 and MMP-14 in the bovine placenta were higher during late gestation, as was observed for EMMPRIN. Therefore, EMMPRIN might regulate trophoblastic cell functions, especially those of binucleate cells, through MMP expression in the bovine placenta.
</description><dc:title>Expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and its expected roles in the bovine endometrium during gestation</dc:title><dc:creator>B. Mishra, K. Kizaki, K. Koshi, K. Ushizawa, T. Takahashi, M. Hosoe, T. Sato, A. Ito, K. Hashizume</dc:creator><dc:identifier>10.1016/j.domaniend.2011.09.004</dc:identifier><dc:source>Domestic Animal Endocrinology 42, 2 (2012)</dc:source><dc:date>2011-10-28</dc:date><prism:publicationName>Domestic Animal Endocrinology</prism:publicationName><prism:publicationDate>2011-10-28</prism:publicationDate><prism:volume>42</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0739-7240(11)X0009-7</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>63</prism:startingPage><prism:endingPage>73</prism:endingPage></item><item rdf:about="http://www.domesticanimalendo.com/article/PIIS0739724011001445/abstract?rss=yes"><title>Effects of calcium salts of long-chain fatty acids and rumen-protected methionine on plasma concentrations of ghrelin, glucagon-like peptide-1 (7 to 36) amide and pancreatic hormones in lactating cows</title><link>http://www.domesticanimalendo.com/article/PIIS0739724011001445/abstract?rss=yes</link><description>Abstract: 
Our objective was to determine the effects of calcium salts of long-chain fatty acids (CLFAs) and rumen-protected methionine (RPM) on plasma concentrations of ghrelin, glucagon-like peptide-1 (7 to 36) amide, and pancreatic hormones in lactating cows. Four Holstein cows in midlactation were used in a 4 by 4 Latin square experiment in each 2-wk period. Cows were fed corn silage-based diets with supplements of CLFAs (1.5% added on dry matter basis), RPM (20 g/d), CLFAs plus RPM, and without supplement. Jugular blood samples were taken from 1 h before to 2 h after morning feeding at 10-min intervals on day 12 of each period. CLFAs decreased dry matter intake, but RPM did not affect dry matter intake. Both supplements of CLFAs and RPM did not affect metabolizable energy intake and milk yield and composition. Plasma concentrations of NEFAs, triglyceride (TG), and total cholesterol (T-Cho) were increased with CLFAs alone, but increases of plasma concentrations of TG and T-Cho were moderated by CLFAs plus RPM. Calcium salts of long-chain fatty acids increased plasma ghrelin concentration, and the ghrelin concentration with CLFAs plus RPM was the highest among the treatments. Plasma concentrations of glucagon-like peptide-1, glucagon, and insulin were decreased with CLFAs, whereas adding RPM moderated the decrease of plasma glucagon concentration by CLFAs. These results indicate that the addition of methionine to cows given CLFAs increases plasma concentrations of ghrelin and glucagon associated with the decrease in plasma concentrations of TG and T-Cho.
</description><dc:title>Effects of calcium salts of long-chain fatty acids and rumen-protected methionine on plasma concentrations of ghrelin, glucagon-like peptide-1 (7 to 36) amide and pancreatic hormones in lactating cows</dc:title><dc:creator>R. Fukumori, T. Sugino, H. Shingu, N. Moriya, Y. Hasegawa, M. Kojima, K. Kangawa, T. Obitsu, S. Kushibiki, K. Taniguchi</dc:creator><dc:identifier>10.1016/j.domaniend.2011.09.005</dc:identifier><dc:source>Domestic Animal Endocrinology 42, 2 (2012)</dc:source><dc:date>2011-11-07</dc:date><prism:publicationName>Domestic Animal Endocrinology</prism:publicationName><prism:publicationDate>2011-11-07</prism:publicationDate><prism:volume>42</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0739-7240(11)X0009-7</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>74</prism:startingPage><prism:endingPage>82</prism:endingPage></item><item rdf:about="http://www.domesticanimalendo.com/article/PIIS0739724011001470/abstract?rss=yes"><title>Age-related changes in gene expression of the growth hormone secretagogue and growth hormone-releasing hormone receptors in Holstein-Friesian cattle</title><link>http://www.domesticanimalendo.com/article/PIIS0739724011001470/abstract?rss=yes</link><description>Abstract: 
Growth hormone secretion from the anterior pituitary gland is controlled by interactions between three hormone receptors, between GHRH and GHRH receptor (GHRH-R), between ghrelin and growth hormone secretagogue receptor (GHS-R1a), and between somatostatin and somatostatin receptors in the hypothalamus and anterior pituitary gland. Ghrelin-GHS-R1a is involved in many important functions, including GH secretion and appetite. We investigated age-related changes in the expressions of GHS-R1a, GHS-R1b (the truncated-type receptor), and GHRH-R mRNAs by real-time reverse transcription-PCR using 16 tissues, leukocytes, oocytes, and cumulus cells in Holstein-Friesian cattle. The tissue samples were divided into three age classes: 1) 19 to 26 d of age (preweaning calves), 2) 2 mo to 6.5 mo of age (postweaning calves), and 3) 3.2 to 8.1 yr of age (cows). The GHS-R1a mRNA was highly (P &lt; 0.05) expressed in the arcuate nucleus, pituitary gland, and liver compared with that of the other tissues in all age classes. Expression of GHS-R 1a mRNA in the arcuate nucleus of postweaning calves was &gt; 10-fold greater (P &lt; 0.01) than those of preweaning calves and cows, and its expression level was the greatest (P &lt; 0.01) in all tissues examined in age group 2. GHS-R1a and GHRH-R mRNA expressions in the pituitary gland of preweaning calves tended to be greater (P &lt; 0.20 and P &lt; 0.17, respectively) than those of postweaning calves and cows. GHS-R1b mRNA expression was detected in all tissues examined, and abundance was greater (P &lt; 0.05) in the pancreas, pituitary gland, spleen, arcuate nucleus, adipose tissue, and leukocyte compared with that of the other tissues examined in age group 3. Interestingly, a relatively large animal-to-animal variation was observed in pancreas GHS-R 1b mRNA expression. The GHRH-R mRNA was markedly increased (P &lt; 0.01) in the pituitary gland in all age groups compared with that of the other tissues. GHRH-R mRNA abundance in the arcuate nucleus, pituitary gland, liver, spleen, adipose tissue, and heart of preweaning calves tended to be greater than those of postweaning calves and cows. The GHRH-R mRNA was not detected in the mammary gland and adipose tissue of nonlactating cows.
</description><dc:title>Age-related changes in gene expression of the growth hormone secretagogue and growth hormone-releasing hormone receptors in Holstein-Friesian cattle</dc:title><dc:creator>M. Komatsu, M. Kojima, H. Okamura, M. Nishio, M. Kaneda, T. Kojima, H. Takeda, A.E.O. Malau-Aduli, H. Takahashi</dc:creator><dc:identifier>10.1016/j.domaniend.2011.09.006</dc:identifier><dc:source>Domestic Animal Endocrinology 42, 2 (2012)</dc:source><dc:date>2011-11-07</dc:date><prism:publicationName>Domestic Animal Endocrinology</prism:publicationName><prism:publicationDate>2011-11-07</prism:publicationDate><prism:volume>42</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0739-7240(11)X0009-7</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>83</prism:startingPage><prism:endingPage>93</prism:endingPage></item><item rdf:about="http://www.domesticanimalendo.com/article/PIIS0739724011001482/abstract?rss=yes"><title>Basal and hormone-stimulated metabolism in lambs varies with breed and diet quality</title><link>http://www.domesticanimalendo.com/article/PIIS0739724011001482/abstract?rss=yes</link><description>Abstract: 
The present study investigated the effects of breed and diet quality on basal and hormone-stimulated energy metabolism in lambs. Twenty-four 7-mo-old merino (MM; n = 12) and second-cross (2X; n = 12) lambs were maintained indoors and fed ad libitum either a low-quality (7.8% crude protein [CP] and 8.1 MJ metabolizable energy [ME]/kg dry matter [DM]) or a moderate-quality (17.6% CP and 9.1 MJ ME/kg DM) diet in a crossover design. After 3 wk of feeding, lambs were injected intravenously with insulin (10 μg/kg body weight [BW]) and epinephrine (0.8 μg/kg BW) on consecutive days and blood samples were collected at −30, −15, −1, 3, 6, 10, 15, 20, 30, 45, 60, 90, and 120 min relative to time of injection. Lambs fed the low-quality diet had lower DM (P &lt; 0.001), CP (P &lt; 0.01), and ME (P &lt; 0.001) intakes than lambs fed the moderate-quality diet. Baseline nonesterified fatty acid (NEFA) concentrations were higher (P &lt; 0.001) in lambs fed a low-quality diet than in those fed a moderate-quality diet but there were no breed differences. Second-cross lambs had higher basal plasma concentrations of glucose (P &lt; 0.001), lactate (P &lt; 0.001), and cortisol (P &lt; 0.02) than the MM lambs, although there was no effect of diet on any of these plasma variables. Insulin injection caused a rapid hypoglycemic response in all lambs but the response was more pronounced (P &lt; 0.01) in MM lambs compared with 2X lambs. The cortisol response to insulin was twice as great (P &lt; 0.05) in MM lambs compared with 2X lambs. There was a rebound in plasma NEFA concentrations after approximately 30 min postinjection that was most pronounced (P &lt; 0.01) in MM lambs. Epinephrine injection caused a rapid increase in plasma NEFA, which tended to be lower in lambs fed the moderate-quality diet (P = 0.07) than in those fed the low-quality diet, but did not differ between breeds. Epinephrine injection caused rapid hyperglycemia, with the response being lower (P &lt; 0.006) in lambs fed the moderate-quality diet compared with those fed the low-quality diet and greater (P &lt; 0.050) in 2X than in MM lambs. Epinephrine injection caused a rapid increase in plasma lactate that tended to be greater (P = 0.07) in 2X lambs compared with MM lambs. The present study demonstrated clear breed differences in basal and hormone-stimulated metabolism, such that the 2X lambs appeared to be less sensitive to insulin and more sensitive to epinephrine than the MM lambs. These metabolic differences may be related to the fundamental differences in physiology that are associated with meat and wool production from 2X and MM breeds, respectively. They may also be related to adaptation of the MM breed to harsh environments through the ability of the body to metabolize fat resources, which are an efficient source of energy for survival.
</description><dc:title>Basal and hormone-stimulated metabolism in lambs varies with breed and diet quality</dc:title><dc:creator>E.N. Ponnampalam, R.D. Warner, F.R. Dunshea</dc:creator><dc:identifier>10.1016/j.domaniend.2011.10.001</dc:identifier><dc:source>Domestic Animal Endocrinology 42, 2 (2012)</dc:source><dc:date>2011-11-28</dc:date><prism:publicationName>Domestic Animal Endocrinology</prism:publicationName><prism:publicationDate>2011-11-28</prism:publicationDate><prism:volume>42</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0739-7240(11)X0009-7</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>94</prism:startingPage><prism:endingPage>102</prism:endingPage></item><item rdf:about="http://www.domesticanimalendo.com/article/PIIS0739724011001494/abstract?rss=yes"><title>Spontaneously obese dogs exhibit greater postprandial glucose, triglyceride, and insulin concentrations than lean dogs</title><link>http://www.domesticanimalendo.com/article/PIIS0739724011001494/abstract?rss=yes</link><description>Abstract: 
Dogs do not appear to progress from obesity-induced insulin resistance to type 2 diabetes mellitus. Both postprandial hyperglycemia and postprandial hypertriglyceridemia have been proposed to cause or maintain beta cell failure and progression to type 2 diabetes mellitus in other species. Postprandial glucose, triglyceride, and insulin concentrations have not been compared in lean and obese dogs. We measured serum glucose, triglyceride, and insulin concentrations in nine naturally occurring obese and nine age- and gender-matched lean dogs. After a 24-h fast, dogs were fed half their calculated daily energy requirement of a standardized diet that provided 37% and 40% of metabolizable energy as carbohydrate and fat, respectively. Fasting and postprandial glucose and triglyceride concentrations were greater in the obese dogs (P &lt; 0.001), although the mean insulin concentration for this group was five times greater than that of the lean group (P &lt; 0.001). Most of the 0.6 mM (11 mg/dL) difference in mean postprandial glucose concentrations between lean and obese dogs was attributable to a subset of persistently hyperglycemic obese dogs with mean postprandial glucose concentrations 1.0 mM (18 mg/dL) greater than that in lean dogs. Persistently hyperglycemic obese dogs had lower triglyceride (P = 0.02 to 0.04) and insulin (P &lt; 0.02) concentrations than other obese dogs. None of the dogs developed clinical signs of diabetes mellitus during follow-up for a median of 2.6 yr. We conclude that pancreatic beta cells in dogs are either not sensitive to toxicity because of mild hyperglycemia or lack another component of the pathophysiology of beta cell failure in type 2 diabetes mellitus.
</description><dc:title>Spontaneously obese dogs exhibit greater postprandial glucose, triglyceride, and insulin concentrations than lean dogs</dc:title><dc:creator>K.R. Verkest, J.S. Rand, L.M. Fleeman, J.M. Morton</dc:creator><dc:identifier>10.1016/j.domaniend.2011.10.002</dc:identifier><dc:source>Domestic Animal Endocrinology 42, 2 (2012)</dc:source><dc:date>2011-12-02</dc:date><prism:publicationName>Domestic Animal Endocrinology</prism:publicationName><prism:publicationDate>2011-12-02</prism:publicationDate><prism:volume>42</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0739-7240(11)X0009-7</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>103</prism:startingPage><prism:endingPage>112</prism:endingPage></item><item rdf:about="http://www.domesticanimalendo.com/article/PIIS0739724011001500/abstract?rss=yes"><title>Altered plasma concentrations of sex hormones in cats infected by feline immunodeficiency virus or feline leukemia virus</title><link>http://www.domesticanimalendo.com/article/PIIS0739724011001500/abstract?rss=yes</link><description>Abstract: 
Gender differences may affect human immunodeficiency virus (HIV) infection in humans and may be related to fluctuations in sex hormone concentration. The different percentage of male and female cats observed to be infected by feline leukemia virus (FeLV) or feline immunodeficiency virus (FIV) has been traditionally explained through the transmission mechanisms of both viruses. However, sexual hormones may also play a role in this different distribution. To study this possibility, 17β-estradiol, progesterone, testosterone, and dehydroepiandrosterone (DHEA) concentrations were analyzed using a competitive enzyme immunoassay in the plasma of 258 cats naturally infected by FIV (FIV+), FeLV (FeLV+), or FeLV and FIV (F−F+) or negative for both viruses, including both sick and clinically healthy animals. Results indicated that the concentrations of 17β-estradiol and testosterone were significantly higher in animals infected with FIV or FeLV (P &lt; 0.05) than in negative cats. Plasma concentrations of DHEA in cats infected by either retrovirus were lower than in negative animals (P &lt; 0.05), and F−F+ cats had significantly lower plasma values than monoinfected cats (P &lt; 0.05). No significant differences were detected in the plasma concentration of progesterone of the four groups. No relevant differences were detected in the hormone concentrations between animal genders, except that FIV+ females had higher DHEA concentrations than the corresponding males (P &lt; 0.05). In addition, no differences were observed in the hormone concentrations between retrovirus-infected and noninfected animals with and without clinical signs. These results suggest that FIV and FeLV infections are associated with an important deregulation of steroids, possibly from early in the infection process, which might have decisive consequences for disease progression.
</description><dc:title>Altered plasma concentrations of sex hormones in cats infected by feline immunodeficiency virus or feline leukemia virus</dc:title><dc:creator>G. Tejerizo, A. Doménech, J.-C. Illera, G. Silván, E. Gómez-Lucía</dc:creator><dc:identifier>10.1016/j.domaniend.2011.11.001</dc:identifier><dc:source>Domestic Animal Endocrinology 42, 2 (2012)</dc:source><dc:date>2011-12-16</dc:date><prism:publicationName>Domestic Animal Endocrinology</prism:publicationName><prism:publicationDate>2011-12-16</prism:publicationDate><prism:volume>42</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0739-7240(11)X0009-7</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>113</prism:startingPage><prism:endingPage>120</prism:endingPage></item></rdf:RDF>
